ArticleMikrochimica acta2026
Ti
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Ofloxacin (OFL) is an effective antibiotic against bacteria. However, the overuse of OFL can lead to residues in animal-derived foods, posing a potential threat to human health. Therefore, it is crucial to design a sensitive and reliable detection platform for OFL. In this study, a ratiometric fluorescent probe was establihed based on Trp-Ce-Ti3C2 quantum dots for the detection of OFL. As the concentration of OFL increased, the fluorescence intensity at 433 nm continuously decreased due to static quenching, and the emission at 495 nm progressively increased due to the formation of a new complex. The developed ratiometric fluorescent probe exhibited a wide detection range (0.1–100 µM) and a low limit of detection (0.07 µM) for the quantitative detection of OFL. The proposed ratiometric fluorescent probe has been successfully applied to the determination of OFL in real samples with satisfactory recoveries (92.80%–116.51%).
Indexed as
Identifiers
41653200What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.